Literature DB >> 32549822

In Defense of Direct-to-Consumer Genetic Testing.

Jeffrey S Bland.   

Abstract

From the earliest days of the ambitious and high-budget Human Genome Project right through to our present-day marketplace of affordable direct-to-consumer (DTC) genetic testing kits, much of the narrative-and controversy-has been focused on genes that tell us about disease risk. The interpretation of genetic information is moving away from the analysis of each gene in isolation and towards the analysis of families of genes that work together to control specific functions in the body (polygenic analysis). This approach has been determined to have a higher level of predictive ability in terms of defining the ways that genetic information can influence individual response to environment, lifestyle, and diet. While disease risk is the purview of specialized medical professionals, perhaps it is time to consider the many ways that DTC genetic testing could be used by consumers as a tool for self-discovery and optimized functional health.
Copyright © 2019 InnoVision Professional Media Inc.

Entities:  

Year:  2019        PMID: 32549822      PMCID: PMC7219454     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  13 in total

1.  Learning one's genetic risk changes physiology independent of actual genetic risk.

Authors:  Bradley P Turnwald; J Parker Goyer; Danielle Z Boles; Amy Silder; Scott L Delp; Alia J Crum
Journal:  Nat Hum Behav       Date:  2018-12-10

2.  Risks and benefits of direct-to-consumer genetic testing remain unclear.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2008-10-01       Impact factor: 56.272

3.  From nutrigenomics to personalizing diets: are we ready for precision medicine?

Authors:  Ruth J F Loos
Journal:  Am J Clin Nutr       Date:  2019-01-01       Impact factor: 7.045

4.  Consuming personal genomics.

Authors:  Jeremy Berg
Journal:  Science       Date:  2019-04-18       Impact factor: 47.728

5.  What Are Polygenic Scores and Why Are They Important?

Authors:  Leo P Sugrue; Rahul S Desikan
Journal:  JAMA       Date:  2019-05-14       Impact factor: 56.272

6.  Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination.

Authors:  Rachele M Hendricks-Sturrup; Anya E R Prince; Christine Y Lu
Journal:  JAMA       Date:  2019-05-21       Impact factor: 56.272

7.  A New Wave of Genomics for All.

Authors:  Diana Crow
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

8.  Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.

Authors:  Kimberly Splinter; David R Adams; Carlos A Bacino; Hugo J Bellen; Jonathan A Bernstein; Alys M Cheatle-Jarvela; Christine M Eng; Cecilia Esteves; William A Gahl; Rizwan Hamid; Howard J Jacob; Bijal Kikani; David M Koeller; Isaac S Kohane; Brendan H Lee; Joseph Loscalzo; Xi Luo; Alexa T McCray; Thomas O Metz; John J Mulvihill; Stanley F Nelson; Christina G S Palmer; John A Phillips; Leslie Pick; John H Postlethwait; Chloe Reuter; Vandana Shashi; David A Sweetser; Cynthia J Tifft; Nicole M Walley; Michael F Wangler; Monte Westerfield; Matthew T Wheeler; Anastasia L Wise; Elizabeth A Worthey; Shinya Yamamoto; Euan A Ashley
Journal:  N Engl J Med       Date:  2018-10-10       Impact factor: 91.245

9.  Risks of presymptomatic direct-to-consumer genetic testing.

Authors:  Justin P Annes; Monica A Giovanni; Michael F Murray
Journal:  N Engl J Med       Date:  2010-08-18       Impact factor: 91.245

10.  Direct-to-Consumer Genetic Testing's Red Herring: "Genetic Ancestry" and Personalized Medicine.

Authors:  Mwenza Blell; M A Hunter
Journal:  Front Med (Lausanne)       Date:  2019-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.